Supportive Care (Antiemetic)
15 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Supportive Care (Antiemetic) (15)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Aprepitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Aprepitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Azasetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Azasetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Casopitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Casopitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Dolasetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Dolasetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Ezlopitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Ezlopitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Fosaprepitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Fosaprepitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Fosnetupitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Fosnetupitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Granisetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Granisetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Netupitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Netupitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Netupitant-Palonosetron Combo |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Netupitant-Palonosetron Combo
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Ondansetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Ondansetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Palonosetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Palonosetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
AprepitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
AzasetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
CasopitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
DolasetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
EzlopitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
FosaprepitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
FosnetupitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
GranisetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
NetupitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
Netupitant-Palonosetron ComboSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
OndansetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
PalonosetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|